Home » Newsletters » BioWorld Science

BioWorld Science

March 29, 2010

View Archived Issues

Dr. Reddy's Laboratories claims new globin transcription factor activators

Merck & Co. discovers new calcitonin receptor CGRP antagonists

Merck Serono discovers Aurora kinase inhibitors for cancer therapy

GlaxoSmithKline claims new antiviral agents for hepatitis C virus infection

Elan discloses novel gamma-secretase inhibitors

New GSK-3 autophosphorylation inhibitor shows preclinical promise in neuroregeneration after injury

Phase II data presented on PROSTVAC-VF immunotherapy in metastatic CRPC

Novartis identifies a new class of potent antimalarials

Betrixaban compares well with warfarin in phase II trial in nonvalvular atrial fibrillation

PLATO substudies assess effects of ticagrelor on arrhythmias and pulmonary function

Flurpiridaz F18 PET detects coronary artery disease with more specificity than [99mTc] SPECT

Ablynx advances inhalable ALX-0171 to preclinical studies for RSV infections

Aradigm completes enrollment in phase II trial of inhaled ciprofloxacin in bronchiectasis

BioSeek and Ono initiate new multiyear drug discovery collaboration

BioAlliance obtains approval for Loramyc in 13 additional European countries

Oramed completes phase IIb trial of oral insulin capsule ORMD-0801 for type 2 diabetes

FDA sets advisory committee review date for Vivus' Qnexa NDA for obesity

Cortex Pharmaceuticals sells selected Ampakine compounds to Biovail

Novelos begins enrollment in phase II trial of NOV-205 in hepatitis C

Traversa and sanofi-aventis to collaborate on development RNAi delivery technology

Bayer to update label for oral contraceptive Yasmin in E.U.

Merck KGaA receives approval for extended use of Erbitux in Japan

Rotarix vaccine not a threat to public safety states EMA

New safety information for ITP therapeutic WinRho(R) SDF in Canada

FDA approves Graceway's Zyclara NDA for actinic keratoses

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026